发明名称 |
METHOD FOR THE TREATMENT OF CANCER |
摘要 |
Provided is a method for determining the prognosis of cancer in a female patient with a solid tumor. The percentage of solid tumor cells expressing TUBB3 protein and the percentage of solid tumor cells expressing TUBB6 protein in a solid tumor sample from the patient is determined. Detection of TUBB6 protein expression in a percentage of solid tumor cells of the female patient that is less than the median percentage expression for TUBB6 protein and detection of TUBB3 protein expression in a percentage of solid tumor cells of the female patient that is less than the median percentage expression for TUBB3 protein indicates a patient with good prognosis; and wherein detection of TUBB6 protein expression in a percentage of solid tumor cells of the female patient that is equal to or greater than the median percentage expression for TUBB6 protein and/or detection of TUBB3 protein expression in a percentage of solid tumor cells of the female patient that is equal to or greater than the median percentage expression for TUBB3 protein indicates a patient with poor prognosis. Also provided is a method of sensitizing a cancer cell from a solid tumor from a male patient other than a prostate cancer cell to treatment with a chemotherapeutic agent comprising administering an effective amount of antiandrogen and a chemotherapeutic agent other than an antiandrogen. The antiandrogen may be administered before, after, or at the same time as the chemotherapeutic agent. |
申请公布号 |
US2012295878(A1) |
申请公布日期 |
2012.11.22 |
申请号 |
US201113109128 |
申请日期 |
2011.05.17 |
申请人 |
FERLINI CRISTIANO;MARIANI MARISA;SHAHABI SHOHREH |
发明人 |
FERLINI CRISTIANO;MARIANI MARISA;SHAHABI SHOHREH |
分类号 |
A61K31/585;A61K31/282;A61K31/4166;A61K31/4745;A61K31/56;A61K31/57;A61P35/00;G01N33/574 |
主分类号 |
A61K31/585 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|